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Loss of TLE3 promotes the mitochondrial
program in beige adipocytes and improves
glucose metabolism
Stephanie Pearson,1 Anne Loft,2 Prashant Rahbhandari,3 Judith Simcox,1 Sanghoon Lee,1
Peter Tontonoz,3 Susanne Mandrup,2 and Claudio J. Villanueva1
1Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA; 2Department of
Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark; 3Department of Pathology
and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California 90095, USA
Prolonged cold exposure stimulates the recruitment of beige adipocytes within white adipose tissue. Beige adipo-
cytes depend on mitochondrial oxidative phosphorylation to drive thermogenesis. The transcriptional mechanisms
that promote remodeling in adipose tissue during the cold are not well understood. Here we demonstrate that the
transcriptional coregulator transducin-like enhancer of split 3 (TLE3) inhibits mitochondrial gene expression in
beige adipocytes. Conditional deletion of TLE3 in adipocytes promotes mitochondrial oxidative metabolism and
increases energy expenditure, thereby improving glucose control. Using chromatin immunoprecipitation and deep
sequencing, we found that TLE3 occupies distal enhancers in proximity to nuclear-encodedmitochondrial genes and
that many of these binding sites are also enriched for early B-cell factor (EBF) transcription factors. TLE3 interacts
with EBF2 and blocks its ability to promote the thermogenic transcriptional program. Collectively, these studies
demonstrate that TLE3 regulates thermogenic gene expression in beige adipocytes through inhibition of EBF2
transcriptional activity. Inhibition of TLE3 may provide a novel therapeutic approach for obesity and diabetes.
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Subcutaneous white adipose tissue (WAT) undergoes sub-
stantial remodeling in response to nutrient availability
and changes in ambient temperature. Cold exposure pro-
motes the recruitment of thermogenic adipocytes—a
long-term adaptive mechanism that facilitates thermo-
genesis (Young et al. 1984). Two distinct subtypes of ther-
mogenic adipocytes have been found in mammals: brown
and beige (Pisani et al. 2011; Wu et al. 2012). Many simi-
larities exist between the two subtypes, including the
presence of small multilocular lipid droplets, increased
mitochondrial number, and the characteristic expression
of the mitochondrial uncoupling protein 1 (UCP1) (Can-
non et al. 1982; Bouillaud et al. 1985). UCP1 transports
protons across the inner mitochondrial membrane with-
out using this potential energy for ATP synthesis (Fedor-
enko et al. 2012), causing the chemical energy of
substrates consumed by the cell in the TCA cycle to be re-
leased as heat (Orava et al. 2011). Beige adipocytes are also
capable of generating heat through a futile creatine kinase
cycle (Kazak et al. 2015). Interest in brown adipose tissue
(BAT) was catalyzed in the early 2000s, when advance-
ments in positron emission tomography (PET) scanning
demonstrated the presence of BAT in adult humans
(Hany et al. 2002; Cypess et al. 2009; Saito et al. 2009; Vir-
tanen et al. 2009).
Despite their functional similarities, beige adipocytes
arise from a lineage separate from brown adipocytes and
are distinctively located as clusters of cells within WAT
depots (Seale et al. 2008; Wu et al. 2012; Ikeda et al.
2018). Not all white adipose tissue is prone to acquire
beige adipocytes: Subcutaneous depots such as the ingui-
nal WAT (iWAT) recruit beige adipocytes in response to
long-term cold exposure or after stimulation by β3 adren-
ergic receptor agonists (de Jesus et al. 2001), whilemuch of
the visceral adipose tissue, such as the epididymal WAT
(eWAT), is resistant to acquiring beige adipocytes.
There has been considerable dispute over the identity of
thermogenic tissue in adult humans, but mounting evi-
dence points to the existence of BAT (Cypess et al. 2013)
as well as populations of cells bearingmarkers of beige ad-
ipocytes (Sharp et al. 2012; Wu et al. 2012). Pathological
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conditions such as pheochromocytoma that lead to excess
catecholamine production are associated with a greater
abundance of beige adipocytes that is thought to promote
a hypermetabolic state (Vergnes et al. 2016; Scheele and
Nielsen 2017). Since the presence of these thermogenic
tissues is inversely related tometabolic disorders and obe-
sity (Orava et al. 2011; Sidossis andKajimura 2015), under-
standing the regulatory mechanisms that govern the
development and activity of thermogenic adipocytes has
become an area of intense therapeutic interest.
All adipocyte subtypes require peroxisome proliferator-
activated receptor γ (PPARγ), which is necessary and suf-
ficient to drive adipocyte differentiation (Tontonoz et al.
1994). A prior genome-wide survey of PPARγ-binding pro-
files from primary cells isolated from three separate tis-
sues (iWAT, eWAT, and BAT) differentiated in vitro
showed an overlap in binding and similar intensities at
the majority of PPARγ-binding sites (Siersbaek et al.
2012). However, this study also revealed a subset of
depot-specific binding sites that correlated well with
depot-specific gene expression (Siersbaek et al. 2012).
These findings suggested that PPARγ likely works in con-
cert with other transcription factors and transcriptional
coregulators to regulate cell type-specific gene expression,
although the identities of these auxiliary factors remain to
be fully elucidated.
Among the transcription factors known to work in con-
certwith PPARγ to determine adipocyte identity are those
of the early B-cell factor (EBF) family. Both EBF1 and EBF2
participate in early adipogenesis (Akerblad et al. 2005; Ji-
menez et al. 2007), and it has been demonstrated recently
that they also play important roles in differentiated adipo-
cytes. EBF1 positively regulates insulin-stimulated glu-
cose uptake and lipogenesis (Griffin et al. 2013; Gao et al.
2014), while EBF2 is selectively expressed in brown adipo-
cytes and facilitates the binding of PPARγ to brown fat-
specific genes to promote thermogenesis (Rajakumari
et al. 2013; Lee andGe 2014). Notably, inWAT, Ebf2 over-
expression enhances beige adipocyte recruitment (Stine
et al. 2016). EBF2 was shown recently to affect chromatin
access via recruiting the chromatin remodeling complex
BAF to brown fat genes (Shapira et al. 2017). The
EBF DNA-binding motif associates with BAT-specific
PPARγ-binding sites (Rajakumari et al. 2013) and enhanc-
es expression of genes important for mitochondrial func-
tion (Shapira et al. 2017). There are a number of known
regulators of EBF2. For example, Blnc1 is a long noncoding
RNA (lncRNA) that forms a ribonucleoprotein complex
with EBF2 to promote thermogenic adipocyte differentia-
tion and function (Zhao et al. 2014). ZFP423,which is pref-
erentially expressed in white adipocytes, has been shown
to inhibit EBF2 activity, causing inhibition of beige adipo-
cyte differentiation (Shao et al. 2016).
The transducin-like enhancer of split (TLE) protein fam-
ily is a highly conserved group of transcriptional coregula-
tors (Fisher and Caudy 1998; Chen and Courey 2000).
Groucho, the TLE ortholog in Drosophila melanogaster,
was first identified as a key regulator of neuronal develop-
ment (Chen and Courey 2000). A high-throughput screen
identified TLE3 as a PPARγ cofactor that promotes white-
specific gene expression (Villanueva et al. 2011, 2013).
TLE3 has been shown to disrupt the interaction between
PRDM16 and PPARγ, causing the BAT of Tle3 transgenic
mice to appear more like WAT, with larger lipid droplets
and higher levels ofWAT-selective transcripts (Villanueva
et al. 2013). During preadipocyte differentiation, TLE3 ac-
tivates PPARγ to promote differentiation of all adipocyte
subtypes and to sustain the lipid storage transcriptional
program after differentiation. Tle3 is expressed in all adi-
pocytes, but its expression is highest in WAT when com-
pared with BAT.
Here we report that conditional deletion of Tle3 in adi-
pocytes promotes the recruitment of beige adipocytes, in-
creases energy expenditure, and leads to improved glucose
metabolism and insulin sensitivity. Analysis of genome-
wide occupancy of TLE3 in adipocytes suggests a direct
role for this cofactor in regulating the nuclear-encodedmi-
tochondrial gene expression program. Moreover, TLE3
binds to genomic regions that also associatewith EBF tran-
scription factors. We define a functional interaction be-
tween TLE3 and EBF2 in which TLE3 attenuates the
EBF2-driven transcriptional program.Our findings outline
a transcriptional mechanism that governs mitochondrial
gene expression and the programming of beige adipocytes.
Results
Conditional deletion of Tle3 in adipocytes promotes
a beige adipocyte transcriptional program
To test the impact of TLE3 onwhole-body energymetabo-
lism, we generated mice with a conditional deletion of
Tle3 in adipocytes. We acclimated the Tle3F/F Adiponec-
tin-Cre (Tle3F/F Adipoq-Cre) mice and their littermate
controls (aged 3–4 mo) to one of two temperature condi-
tions—thermoneutrality (30°C) or cold exposure (4°C)—
for 7 d. At the conclusion of the study, the iWAT, eWAT,
andBATdepotswere fixed, sectioned, and stainedwithhe-
matoxylin and eosin (H&E). Under thermoneutral condi-
tions, we observed no differences in adipose histology
between control and Tle3F/F Adipoq-Cre mice (Fig. 1A,
top panel). However, whenmicewere subjected to cold ex-
posure, both groupshad reduced lipiddroplet size in iWAT,
but, strikingly, thereweremoremultilocular cells, consis-
tent with beige adipocytes in the Tle3F/F Adipoq-Cremice
(Fig. 1A, bottom panel). In contrast, both eWAT and BAT
showed similar histological features between control and
Tle3F/F Adipoq-Cre mice in the setting of cold exposure
(Fig. 1A).Noalterationswereobserved in livermorphology
at thermoneutrality or at 4°C (Supplemental Fig. S1A).We
measured gene expression within iWAT following 4 d of
cold exposure and found increased expression of thermo-
genic-associated genes, such as Cited, Dio2, Elovl3,
Eva1,Tmem26, andUcp1, while the genes encoding gene-
ral adipocytemarkers such asAdipoq and Fabp4 remained
unchanged (Fig. 1B). In these circumstances, the changes
were specific to iWAT, as no changes in gene expression
were observed between control and Tle3F/F Adipoq-Cre
mice in the eWAT or BAT depots during cold exposure
(Supplemental Fig. S1B). After 1 wk at thermoneutrality,
Pearson et al.
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therewere no significant differences identified in the ther-
mogenic gene expression program in iWAT; although sev-
eral thermogenesis-associated genes showed trends of
increased expression in the Tle3F/F Adipoq-Cre mice, the
overall levels were low after 1 wk of thermoneutrality
(Supplemental Fig. S1C).
The greater recruitment of beige adipocytes was further
verified by the finding of increasedUCP1 protein in iWAT
of Tle3F/F Adipoq-Cre mice (Fig. 1C). As beige adipocytes
are rich inmitochondria, we alsomeasuredmitochondrial
content by blotting for proteins from each of the electron
transport chain complexes. After 4 d of cold exposure, the
iWAT from Tle3F/F Adipoq-Cre mice expressed more pro-
tein from each subunit than the littermate controls, with
marked increases in the cytochrome oxidase complex IV
(Fig. 1D).
Loss of Tle3 in adipocytes increases whole-body energy
expenditure
We next proceeded to monitor the animal during cold ex-
posure and observed greater weight loss over time in the
Tle3F/F Adipoq-Cre mice as compared with Tle3F/F con-
trols (Fig. 1E). To assess whether these changes in body
weight were due to decreased food consumption or in-
creased energy expenditure, we placed age-matched mice
in metabolic cages at 4°C for a 3-d period. We observed
no differences in body weight or body composition be-
tween the twogroupsprior to cold exposure (Supplemental
Fig. S1D). Tle3F/F Adipoq-Cre mice also showed an in-
crease in energy expenditure at 4°C in both day and night
when compared with the control group (Fig. 1F). Measure-
ments of O2 consumption and CO2 production (Supple-
mental Fig. S1E) revealed a modest but consistent
increase in the cold. During this period, we did not find
measurable differences in food consumption or activity
(Supplemental Fig. S1F).
TLE3 regulates glucose utilization and insulin sensitivity
We next assessed whether having more beige adipocytes
in the setting of Tle3 deletion promoted glucose utiliza-
tion. As increased beige adipose tissue and BAT have
been linked previously to improvements in glucose
B
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Figure 1. Conditional deletion of Tle3 in adipocytes promotes beige adipocyte programming and whole-body energy expenditure.
(A) Histological analysis of iWAT, eWAT, and BAT at thermoneutrality (30°C) and cold (4°C) for control (Tle3F/F) and knockout (Tle3F/F Adi-
poq-Cre) mice. Scale bar, 500 µm. (B) Expression of adipogenic- and thermogenic-associated genes from the iWAT, measured by real-time
PCR after 4 d of cold exposure and normalized to 36B4. (C ) UCP1 protein expression in iWAT after 4 d of cold exposure. (D) Protein ex-
pression for oxidative phosphorylation proteins in iWAT after 4 d of cold exposure. (E) Time-dependent changes in bodyweight for Tle3F/F
and Tle3F/F Adipoq-Cre mice housed at 4°C. n =4 per group. (F ) Energy expenditure as measured by indirect calorimetry in the compre-
hensive laboratory animal-monitoring system (CLAMS)metabolic cages forTle3F/F andTle3F/F Adipoq-Cremice. n =4 per group. Data are
presented as mean± SEM. Significance was analyzed by two-tailed Student’s t-test. (∗) P <0.05; (∗∗) P <0.01.
Transcriptional programing of beige adipocytes
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handling (Lee et al. 2010; Stanford et al. 2013), we asked
whether the Tle3F/F Adipoq-Cre mice had improved glu-
cose clearance. We performed glucose tolerance tests
(GTTs) on Tle3F/F Adipoq-Cre and control mice that had
been acclimated to thermoneutrality for 1 wk, followed
by 4 d of cold exposure and a second GTT. No differences
were observed in the glucose excursion curves at 30°C
(Fig. 2A). After cold acclimation, the Tle3F/F Adipoq-Cre
mice had improved glucose handling and significantly
lower glucose area under the curve (AUCg) (Fig. 2B). We
performed an insulin tolerance test (ITT) following the
same procedure, and while no differences were seen be-
tween the two groups at 30°C, cold acclimation improved
insulin sensitivity to a significant degree in the Tle3F/F
Adipoq-Cre group (Fig. 2C,D). We did note that both
groups of mice demonstrated improved glucose handling
in both GTTs and ITTs after cold acclimation, but, in
both cases, the change was greatest in the Tle3F/F Adi-
poq-Cre group (Fig. 2E). No significant differences were
observed in plasma insulin levels between the two groups
after cold exposure (Supplemental Fig. S2A).
Under these conditions, beige adipocytes represent a
small fraction of the total adipocyte content of the body.
This led us to askwhether beige adipocyteswere abundant
enough to account for these changes in glucose handling.
With cold exposure, we observed increases in the expres-
sion of Glut1 and Glut4 transporters in the iWAT depot
of Tle3F/F Adipoq-Cre mice but not in the BAT or eWAT
(Supplemental Fig. S2B), but this only indicates that the
tissue is poised to augment glucose clearance. To directly
test the contribution of beige adipocytes to the phenotype
of Tle3F/F Adipoq-Cre mice, we performed in vivo glucose
uptake assays with uniformly labeled 14C-2-deoxyglucose
inmice housed for 4 d at 4°C. Thirtyminutes following ra-
diolabeled glucose administration, the animals were
euthanized, tissues were excised, and the radioactive con-
tent of each tissue wasmeasured. Glucose uptake in Tle3-
deficient iWAT was increased threefold compared with
controls, while BAT and eWAT had minimal changes
(Fig. 2F). We note that the skeletal muscle in the Tle3F/F
Adipoq-Cre mice trended toward increased glucose up-
take, suggesting that the glucose improvementsmaybe af-
fected by the interplay between fat and muscle, although
these data did not reach statistical significance (Supple-
mental Fig. S2C). These data suggest that the changes in
whole-body glucose handling observed in the Tle3F/F
A C
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Figure 2. Deletion of Tle3 in adipocytes improves glucose handling with cold exposure. (A) GTT and AUGg on control (Tle3F/F) and
knockout (Tle3F/F Adipoq-Cre) mice after 1 wk at thermoneutrality (30°C). n =6–7 per group. (B) GTT and AUCg following 4 d in cold
(4°C). n =6–7 per group. (C ) ITT and AUCg on Tle3
F/F and Tle3F/F Adipoq-Cre mice after 1 wk at thermoneutrality and cold. n =6–7 per
group. (D) ITT and AUCg following 4 d in the cold (4°C). n =6–7 per group. (E) Change in measured AUCg for GTT and ITT from thermo-
neutrality to after cold exposure. (F ) Uptake of 2-[U-14C]-deoxyglucose in BAT, iWAT, and eWAT for Tle3F/F and Tle3F/F Adipoq-Cremice
following 4 d of cold exposure. n =4 per group. Data are presented asmean±SEM. Significancewas analyzed by two-tailed Student’s t-test.
(∗) P<0.05.
Pearson et al.
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Adipoq-Cre mice may be driven by uptake into beige adi-
pose tissue and that increased beige adipose tissue is capa-
ble of regulating systemic glucose metabolism.
TLE3 intrinsically regulates the thermogenesis
and glucose clearance in beige adipocytes
Beige adipocytes rely on both intrinsic regulation and sys-
temic signaling to control their recruitment. To ascertain
whether the phenotypic changes that we observed in vivo
were due to alterations in TLE3-dependent gene transcrip-
tion, we used immortalized Tle3F/F iWAT preadipocytes
with a tamoxifen-inducible Cre (pMSCV2-CreERT2).
Because TLE3 is known to be involved in early adipocyte
differentiation (Villanueva et al. 2011), we chose to knock
out Tle3 4 d after the differentiation cocktail was admin-
istered and harvest cells on the 10th day. To ensure that
the differentiation potential was not affected by knocking
outTle3 at this time point, we stained for lipids using both
Oil Red O and Bodipy and found similar lipid accumula-
tion in Tle3-knockout cells when compared with controls
(Fig. 3A). In this in vitro system, the loss of TLE3 led to in-
creased UCP1 protein but no change in PPARγ protein
levels (Fig. 3B). Furthermore, these protein changes were
accompanied by increases in other thermogenesis-associ-
ated transcripts, including Cd36, Cidea, Cox5b, Cox7a1,
Dio2, Ebf2, Eva1, Ppargc1a, Prdm16, Tmem26, and
Ucp1, while no changes were observed in transcript levels
of the adipocyte differentiation markers Fabp4 and Adi-
poq. In contrast, no changes were observed in the thermo-
genesis gene program in the empty vector (pMSCV2) cells
when treated with tamoxifen (Fig. 3C). Similar to our in
vivo findings, we found increased expression of the
Glut4 glucose transporter in the tamoxifen-treated
CreERT2 cells that was not observed in the empty vector
cells (Supplemental Fig. S3A). To further ensure that ta-
moxifen treatment itself was not responsible for the
changes in gene expression, Tle3F/F cells were infected
with Cre-expressing adenovirus, where we observed in-
creases in Ucp1 expression (Supplemental Fig. S3B).
Having established an in vitro model for the beige adi-
pocyte recruitment that we observed in vivo, we next per-
formed in vitro glucose uptake with uniformly labeled
14C-2-deoxyglucose to determine whether the glucose
A C
B
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Figure 3. Deletion of Tle3 promotes the programming of beige adipocytes and glucose clearance in vitro. (A) Oil Red O (top) and DAPI/
Bodipy (bottom) staining of Tle3F/F iWAT adipocytes expressing CreERT2 and treated with either EtOH (control) or 4-hydroxytamoxifen
on day 4 after administration of differentiation cocktail and stained on day 10. (B) Protein expression of UCP1 and TLE3 by immunoblot in
Tle3F/F CreERT2 iWAT adipocytes differentiated in culture. (C ) Gene expression measured by real-time PCR in Tle3F/F pMSCV2 (empty
vector) andCreERT2 iWAT adipocytes differentiated in culture. Datawere normalized to 36B4. n=3 per group. (D) In vitro glucose uptake
of 2-[U-14C]-deoxyglucose in Tle3F/F iWAT adipocytes expressing either pMSCV2 or CreERT2. n=4 per group. (E) Oxygen consump-
tion rate (OCR) of Tle3F/F CreERT2 iWAT adipocytes, as measured by Seahorse XF analyzer. n =14 per group. Data are presented as
mean±SEM. Significance was analyzed by two-tailed Student’s t-test. (∗) P<0.05; (∗∗) P<0.01.
Transcriptional programing of beige adipocytes
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clearance observed previously was due to intrinsic chang-
es or whether Tle3-deficient iWATwas responding to sys-
temic signaling. Upon the administration of tamoxifen to
differentiated CreERT2-expressing cells, the loss of TLE3
causes approximately a fourfold increase in glucose up-
take, while no changewas observed pMSCV2 cells treated
with tamoxifen (Fig. 3D). We also observed that the loss of
TLE3 led to increases in oxygen consumption during basal
respiratory conditions, isolated proton leak, and ATP pro-
duction (Fig. 3E), demonstrating a rise in energy utiliza-
tion in beige adipocytes lacking TLE3.
TLE3 promotes diet-induced weight gain and glucose
intolerance
We appreciate that 4°C cold exposure represents a severe
thermogenic stimulus and wanted to understand whether
the loss of adipose TLE3 could affect systemicmetabolism
in the absence of a cold stimulus. Therefore, the Tle3F/F
Adipoq-Cre mice and their littermate controls were
placed on a high-fat diet (HFD; 60% fat; 5.2 kcal/g) for a
period of 14 wk and housed at ambient temperature (22°
C–24°C). We monitored body weight weekly and found
that the Tle3F/F Adipoq-Cre mice were protected against
weight gain on a HFD (Fig. 4A). Analysis of body composi-
tion revealed that the control group had higher body fat
beginning after 6 wk on a HFD, and the difference was
maintained until the end of the study (Fig. 4B). To test
whether loss of TLE3 in this setting was also associated
with improved glucose clearance, we performed a GTT.
We observed elevated fasting glucose levels in both
groups, but the Tle3F/F Adipoq-Cre mice showed en-
hanced glucose excursion (Fig. 4C). When compared
with littermate controls, Tle3F/F Adipoq-Cre mice also
showed enhanced insulin response on an ITT (Fig. 4D).
Notably, the iWAT fat pads of the Tle3F/F Adipoq-Cre
mice weighed less than those of the control group (Fig.
4E), while tissue weight of BAT, eWAT, and the liver
were similar between control and Tle3F/F Adipoq-Cre
mice (Supplemental Fig. S4A). The gross morphology
demonstrates that iWAT fat depots appeared smaller in
the Tle3F/F Adipoq-Cre mice, but no other differences in
tissues between the two groups were visible (Supplemen-
tal Fig. S4B). Histology indicated that the Tle3F/F Adipoq-
Cre mice also had more beige adipocytes than the control
group on a HFD (Fig. 4F). Together, these findings suggest
thatTLE3contributesto the impairmentofdiet-associated
weight gain and glucose intolerance.
BA C
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Figure 4. Conditional deletion of TLE3 in adipocytes protects against diet-induced weight gain and glucose intolerance. (A) Time course
of body weight for control (Tle3F/F) and knockout (Tle3F/F Adipoq-Cre) mice housed at ambient temperature on a 60%HFD for 14 wk. n =
6–8 per group. (B) Body fat composition by NMR in Tle3F/F and Tle3F/F Adipoq-Cre groups on a 60% HFD over time. n =6–8 per group.
(C ) GTT and AUGg on Tle3
F/F and Tle3F/F Adipoq-Cre mice after 14 wk on a 60% HFD. n= 6–7 per group. (D) ITT and AUCg on Tle3
F/F
and Tle3F/F Adipoq-Cre mice after 10 wk on a 60% HFD. n =3 per group. (E) Weight of individual iWAT tissue depots. n= 10 per group.
(F ) Histology of adipose depots after 14 wk on a 60% HFD. Data are presented as mean±SEM. Significance was analyzed by two-tailed
Student’s t-test. (∗) P<0.05; (∗∗) P<0.01.
Pearson et al.
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Genome-wide analysis reveals preferential association
of TLE3 with WAT genes
TLE3was initially identified as a transcriptional coactiva-
tor of PPARγ during early adipocyte differentiation (Villa-
nueva et al. 2011). To develop a broader understanding of
TLE3’s role in regulating gene expression, we performed
genome-wide chromatin immunoprecipitation (ChIP) fol-
lowed by deep sequencing (ChIP-seq). The specificity of
the antibody was verified using differentiated preadipo-
cytes immortalized from iWAT stromal vascular frac-
tions of Tle3 floxed mice. Cells were treated with
adenovirus expressing Cre-recombinase or LacZ, and
ChIP with the TLE3 antibody was performed. Quantita-
tive ChIP-PCR was performed on known TLE3-binding
sites near Pparγ, Fabp4, Adipoq, Aqp7, and Angptl4.
The limited recovery after TLE3 depletion indicates lim-
ited cross-reactivity of the TLE3 antibody (Supplemental
Fig. S5A). Our ChIP-seq analysis was performed in
eWAT-, iWAT-, and BAT-derived adipocytes using cul-
tures with at least 50% differentiation and showing sim-
ilar expression levels of general adipocyte markers
(Supplemental Fig. S5B). We found that TLE3 had a great-
er number of binding sites in both eWAT and iWAT as
compared with BAT in terms of both number of binding
sites (Fig. 5A) and binding intensity (Fig. 5B). These find-
ings are consistent with the previous report showing low-
er TLE3 expression in BAT (Villanueva et al. 2013).
Although TLE3 mapped to many common sites within
the three adipocyte subtypes, we also identified unique
binding sites for each adipocyte subtype (Fig. 5A).
The genomic distribution of TLE3 mapped principally
to distal regions of the mouse genome (Fig. 5C), an obser-
vation that is consistentwith the TLE/Groucho family be-
ing located primarily at enhancers (Chambers et al. 2017;
Dali et al. 2018). There was nearly equal distribution of
binding upstream of and downstream from the transcrip-
tional start site (TSS) (Supplemental Fig. S5C). Despite
unique elements of TLE3 binding in each tissue, the distri-
bution of TLE3was largely similar between iWAT, eWAT,
and BAT (Supplemental Fig. S5D). Through our genomic
analysis, we found that 61% of TLE3-binding sites are
>25 kb distal from the TSS. TLE3 was shown previously
by ChIP-qPCR to occupy the Fabp4 enhancer/promoter.
A closer examination of our ChIP-seq data set revealed
several TLE3-binding sites near the Fabp4 gene. Using
data from a PPARγ ChIP-seq of differentiated progenitors
of eWAT, iWAT, and BAT (Siersbaek et al. 2012), we ob-
served that TLE3 occupancy overlapped with multiple
prominent PPARγ-binding sites (Fig. 5D). TLE3 was re-
ported previously to interactwith PPARγ at the promoters
of key adipocyte target genes (Villanueva et al. 2011).
B CA
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Figure 5. Genome-wideprofiling ofTLE3 in adipocytes reveals increasedbinding inWAT. (A) Venndiagramdemonstrating thenumberof
TLE3-binding sites in eWAT, iWAT, and BAT, filtered for >15 tags and >10-fold above input. (B) Binding intensity at sites occupied byTLE3
in differentiated adipocytes from eWAT, iWAT, and BAT. (C ) Genomic distribution of TLE3 relative to the distance from transcriptional
start sites (TSSs). (D) Genome browser tracks of Fabp4 for TLE3 and PPARγ in eWAT, iWAT, and BAT. (E) Genome browser tracks of
Ppargc1α for TLE3 and PPARγ in eWAT, iWAT, and BAT. (F ) Genome browser tracks of Ucp1 for TLE3 and PPARγ in eWAT, iWAT,
and BAT.
Transcriptional programing of beige adipocytes
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To determine the overlap in binding sites between TLE3
and PPARγ, we aligned TLE3 and PPARγ ChIP-seq data
sets and found that 23% of TLE3WAT-binding sites over-
lap with PPARγ, while 41% of PPARγWAT-binding sites
overlap with TLE3 (Supplemental Fig. S5E). PPARγ
WAT-binding sites were defined as PPARγ-binding sites
shared between eWAT and iWAT. Interestingly, genes an-
notated to overlapping TLE3- and PPARγ-binding sites in-
cluded genes involved in several metabolic pathways
(Supplemental Fig. S5F), and motif analysis in these over-
lapping binding sites suggests a possible interaction
between TLE3, PPARγ, and other known adipocyte tran-
scription factors (Supplemental Fig. S5G). Examples of
the distribution of TLE3-binding sites relative to PPARγ
can be seen at Fabp4, Ppargc1a, and Ucp1 (Fig. 5D–F).
When we examined other genes associated with thermo-
genesis, such as Ppargc1a and Ucp1, we noted multiple
nearbyTLE3-binding sites overlappingwith putative regu-
latory regions as detected by DNase I hypersensitivity
sites (DHS) (Fig. 5E,F). Together, the observations demon-
strate that both Ppargc1a andUcp1 are elevated with the
loss ofTLE3 (Fig. 3C), and, since these genes are also bound
byTLE3, it raises the possibility thatTLE3might be acting
to repress their expression.
Loss of TLE3 stimulates the thermogenic gene expression
program in iWAT
Thus far, we had observed changes in thermogenic genes
by real-time PCR in vitro and in vivo and, through ChIP-
seq, found that TLE3 binds in proximity to these genes
but had only limited insights into how the overall tran-
scriptional landscape of the cells was changing in the ab-
sence of TLE3. To define the global changes in gene
expression provoked by alteration in TLE3 expression,
we used the tamoxifen-inducible Tle3F/F preadipocytes
expressing CreERT2. After 4 d of differentiation, we
knocked out Tle3 by tamoxifen administration, harvested
the cells on the 10th day of differentiation, and then as-
sessed changes in gene expression by RNA sequencing
(RNA-seq). Consistent with our previous findings, Tle3
deletion led to the up-regulation of genes associated
with the thermogenic gene expression program, including
Cidea,Ucp1, and Ppargc1a (Fig. 6A). Of the 765 genes up-
regulated in the TLE3 knockout cells, 469 may be direct
targets of TLE3, as their expression increased in the ab-
sence of TLE3 and they have a TLE3-binding site nearby.
Wenote that, among these genes, there is an overrepresen-
tation of genes that have a role in mitochondrial function,
including those that are associated with the heat produc-
tion pathway, including Aldh4a1, Cox7a1, Ndufc2, and
Cox5a (Supplemental Fig. S6A). Of the 539 genes that
were down-regulated in the Tle3 knockout, 475 have a
TLE3-binding site nearby (Fig. 6B). The distribution of
TLE3-binding sites associated with TLE3-regulated genes
shows a greater number of binding sites downstream from
the TSS when compared with the number of upstream
binding sites (Supplemental Fig. S6B). Our finding that
up-regulated and down-regulated genes have proximal
TLE3-binding sites is consistent with a dual role of
TLE3 in activating or inhibiting gene expression (Villa-
nueva et al. 2011).
To characterize the gene program regulated by TLE3,
we performed gene ontology analysis using the subset of
genes in iWAT thatwere repressed by TLE3 and had an as-
sociated TLE3 site. We found overrepresentation of genes
that encode proteins in metabolic pathways and are in-
volved in energy utilization (Fig. 6C). Notably, the path-
way encompassing heat production by the uncoupling
proteins was ranked third highest in significance among
those pathways, supporting the notion that TLE3 acts
physiologically to counteract this program. A heat map
of the changes for all genes included in this pathway is
shown (Fig. 6D; Supplemental Table S1).
We also performed gene ontology analysis on genes that
were decreased with the loss of TLE3 and had an associat-
ed TLE3 site. This analysis showed an enrichment for
pathways associated with the extracellular matrix, al-
though the statistical significance of this association
was lower in comparison with pathways that were up-reg-
ulated by Tle3 deletion (Fig. 6E). Using Tle3F/F adipocytes
expressing CreERT2, we verified that the loss of TLE3
does repress both Col6a1 and Col6a2 and, using iWAT
from HFD-fed mice, saw a decrease in expression of
Mmp19 (Supplemental Fig. S6C) and noted that these
genes have TLE3-binding sites nearby (Supplemental
Fig. S6D). Together, these data suggest that TLE3 has a
role in promoting adipose tissue fibrosis and that the glu-
cose improvements seen in Tle3 knockout mice might
partially be due to decreases in the fibrotic gene program.
TLE3 motif analysis predicts functional interaction
with EBFs
Because TLE3 lacks a DNA-binding domain, its ability to
modulate gene expression depends on interactions with
DNA-binding transcription factors. To identify putative
transcription factors that recruit TLE3, we completed de
novomotif analysis on the top 1000 genomic regions iden-
tified byTLE3ChIP-seq and found sequences thatwere as-
sociated with C/EBP, EBF, FRA1, RUNX, NFIA, TBX20,
RUNX1, and ASCL1 motifs (Fig. 7A). Analysis of individ-
ual adipocyte subtypes showed slight variations in the list
of transcription factors. Of particular interest was the
finding thatC/EBP and EBFmotifswere consistently high-
ly enriched in sites where TLE3was bound (Supplemental
Fig. S7A).
To understand the mechanisms by which TLE3 modu-
lates the recruitment of beige adipocytes in inguinalwhite
adipocytes, we analyzed TLE3-binding sites that overlap
with PPARγ. We found that the C/EBP and the EBF motif
were enriched at PPARγ sites that are associated with
TLE3 (Supplemental Fig. S7B). Given the potential cross-
talk of these transcription factors, we next analyzed puta-
tive target genes of TLE3 in iWAT adipocytes (i.e., genes
that were repressed or induced by TLE3 knockout and dis-
play nearby TLE3 binding) (Supplemental Fig. S7C). Inter-
estingly, the EBF motif was present in a higher fraction of
TLE3-binding sites near genes that were repressed by
TLE3 compared with genes that were enhanced by TLE3
Pearson et al.
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(Fig. 7B). This was not observed for the C/EBP motif,
where we found a similar number of C/EBP motifs in
genes stimulated or repressed by TLE3 (Supplemental
Fig. S7D). Also, some of the transcripts regulated by
TLE3 have been reported to be direct targets of EBF2 (Raja-
kumari et al. 2013). We therefore analyzed the coinci-
dence of TLE3 and EBF2 binding near genes regulated by
TLE3 on a genome-wide level. We compared ChIP-seq
data sets from EBF2 in BAT (Shapira et al. 2017) with
the TLE3-binding profile in iWAT and found a greater
overlap between TLE3- and EBF2-binding sites near genes
that were repressed by TLE3 compared with genes en-
hanced by TLE3 (Fig. 7C). The binding intensity of EBF2
was higher in TLE3-binding sites near repressed genes
(Fig. 7D), suggesting that cross-talk between TLE3 and
EBF2 occurs primarily near genes directly repressed by
TLE3.
To test the functional connection between TLE3 and
EBFs, we explored interactions between TLE3 and EBF1,
EBF2, and EBF3. Cells were transfected with Flag-TLE3
in the presence or absence of V5-tagged EBF proteins, im-
munoprecipitated with anti-V5 antibody, and immuno-
blotted with anti-Flag antibody. We found that TLE3
coimmunoprecipitated with EBF1, EBF2, and EBF3 (Fig.
7E). Seeking whether the endogenous proteins would in-
teract, we also used Tle3F/F iWAT preadipocytes treated
CA
EB
D
Figure 6. TLE3 represses TCA cycle and thermogenic gene program in iWAT. (A) Volcano plot showing differentially expressed genes in
beige adipocytes isolated from Tle3F/Fmice expressing CreERT2. Cells were treated with EtOH (control) or 4-hydroxytamoxifen on day 4
after differentiation and harvested on day 10. Adjusted P-value of <0.01; log2 ratio of differential expression >|0.2|. (B) Stacked bar graph
demonstrating genes that are differentially regulated with the loss of TLE3 with or without a TLE3-binding site. RNA-seq genes with ad-
justed P-value of <0.05, no distance from TSS cutoff applied. (C ) Gene ontology analysis of 475 genes whose expression is increased with
loss of TLE3 andwhich have at least one TLE3 occupancy site identified byChIP-seq. Reactome pathways (P< 0.0005) are listed in order of
decreasing P-value. (D) Gene ontology analysis of 469 genes whose expression is decreased with loss of TLE3 and which have at least one
TLE3 occupancy site identified by ChIP-seq. Reactome pathways (P<0.0005) are listed in order of decreasing P-value. (E) Heat map of
genes associated with Reactome pathway R-MMU-163200 (respiratory electron transport, ATP synthesis by chemiosmotic coupling,
and heat production by uncoupling proteins) in Tle3F/F iWAT adipocytes expressing CreERT2 and treated with either EtOH (control)
or 4-hydroxytamoxifen. Z-score reflects the log2 ratio. n= 3 per group.
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with either ethanol or tamoxifen and immunoprecipitat-
ed the cell lysates with an antibody that detects TLE3.
Blotting for EBF2 demonstrated a specific interaction be-
tween TLE3 and EBF2 (Fig. 7F). Because we observed
that TLE3 and EBF2 colocalized near several putative tar-
get genes, we sought to investigate how TLE3 influenced
the transcriptional activity of EBF2.We used the ChIP-seq
data of TLE3 and EBF2 (Lai et al. 2017) to identify a site
where both TLE3 and EBF2 colocalized in proximity to
BAT-selective markers and identified Cldn1 (Supplemen-
tal Fig. S7E). Day 2 differentiated beige adipocytes were
transfected with a luciferase reporter driven by the 0.5-
kb enhancer element upstream of the Cldn1 gene. This
enhancer elementwas defined as a DHS site that has over-
lapping TLE3 and EBF2 occupancy (Supplemental Fig.
S7E). The cells were also transfected with an Ebf2 expres-
sion vector,Tle3 expression vector, or both.We found that
EBF2 activated the Cldn1 reporter and that reporter ex-
pression was inhibited to baseline levels when TLE3 was
also expressed (Fig. 7G). Finally, we performed Ebf2
knockdown experiments in Tle3F/F iWAT adipocytes ex-
pressing CreERT2. Cells were treated with either DMSO
or tamoxifen on day 4 of differentiation and subsequently
transfected with either a control scramble siRNA (siSCR)
or an siRNA targeting Ebf2 (siEbf2) on day 12. Cells were
harvested on day 14 of differentiation to measure expres-
sion of genes under the control of EBF2 (Fig. 7H). Ebf2
mRNA levels were reduced, and we observed a corre-
sponding decrease in expression levels of several beige
fat-associated genes, including Cidea, Cox8b, Dio2, and
Ucp1. In the control siSCR group, the loss of TLE3 caused
an increase in mRNA levels of those same genes. Howev-
er, the loss of TLE3 failed to induce expression in the case
of Ebf2 knockdown. Together, these findings suggest that
the effects on thermogenic gene expression seen with the
loss of TLE3 are mediated through EBF2.
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Figure 7. Analysis of TLE3 binding demonstrates repressive interaction with EBF2. (A) De novo motif analysis of the top 1000 TLE3 oc-
cupancy sites inWAT and their assigned closestmatching transcription factor, listed in order of decreasing P-value. (B) Knownmotif anal-
ysis of the EBF motif in TLE3-binding sites and matching background sequences within 15 kb of the indicated gene groups. (C ) Overlap
between TLE3- and EBF2-binding sites within 15 kb of the indicated gene groups with randomly selected GC content-matching back-
ground sequences. (D) EBF2 ChIP-seq signal in TLE3-binding sites within 15 kb of the indicated gene groups. (E) Coimmunoprecipitation
of TLE3 and EBF proteins from293 cells transfectedwith Flag-TLE3 and one of the following: EBF1-V5, EBF2-V5, or EBF3-V5. Lysates were
immunoprecipitated with anti-V5 antibody. (F ) Coimmunoprecipitation of TLE3 and EBF2 from Tle3F/F iWAT adipocytes expressing
CreERT2 and treated with either EtOH (control) or 4-hydroxytamoxifen. Lysates were immunoprecipitated with anti-TLE3 antibody.
(G) Analysis of Cldn1 enhancer activation of luciferase reporter by coexpression of EBF2, TLE3, or both in beige adipocytes differentiated
in vitro. n =3 per group. (H) Gene expression of Tle3F/F iWAT adipocytes expressing CreERT2. Cells treated with DMSO (control) or
4-hydroxytamoxifen on day 4 of differentiation and either siSCR or siEBF2 on day 12 of differentiation and harvested on day 14 of differ-
entiation. n =3 per group. Data are presented as mean±SEM. Significance was analyzed by Fisher’s exact test (B,C ), Wilcoxon rank sum
test (D), or Student’s t-test (G,H). (∗) P <0.05; (∗∗) P <0.01; (∗∗∗) P<2.2 × 10−8; (∗∗∗∗) P <2.2 × 10−16.
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Discussion
Subcutaneous WAT has a tremendous capacity to change
its morphology in response to the cold. Mice that are ac-
climated to the cold acquire thermogenic cells that are
rich in mitochondria and are believed to play a long-
term adaptive role in thermogenesis. The mechanisms
that regulate the mitochondrial gene expression program
in beige adipocytes are incompletely understood. Here we
outlined a role for the transcriptional cofactor TLE3 in
regulating the mitochondrial beige adipocyte program.
The loss of Tle3 in adipocytes promotes the recruitment
of beige adipocytes in the iWAT tissue depot in response
to long-term cold exposure, as shown by gross histolo-
gical analysis, transcriptional changes, and increased ex-
pression of UCP1. Our findings further support the
concept that increasing beige adipocyte number can
lead to improvements in glucose metabolism and insulin
sensitivity. We demonstrated that TLE3 regulates the mi-
tochondrial gene expression program in beige adipocytes
and provide evidence indicating that this occurs through
countering the action of EBF2, a transcription factor that
promotes the recruitment of thermogenic cells (Rajaku-
mari et al. 2013; Stine et al. 2016). These studies high-
light that mechanisms that promote the recruitment of
beige adipocytes can prevent weight gain associated
with a HFD.
Our findings strongly support the contention that pro-
moting an increase in beige adipocyte activity is suffi-
cient to have beneficial effects on systemic glucose
metabolism. We found that loss of Tle3 improved glucose
metabolism in the setting of cold exposure but not at
thermoneutrality and that this effect was correlated
with the abundance of beige adipocytes. We found differ-
ences in histology and gene expression consistent with
beige adipocytes between control and Tle3-deficient
mice during cold exposure but not thermoneutrality,
strongly suggesting that increasing the amount of beige
fat alone can lead to improvements in glucose metabo-
lism. When testing to see which adipose tissue depots
were primarily involved in clearing glucose, we found
that the iWAT depots had the greatest increase in glucose
uptake. Thus, despite the fact that they represent a small
fraction of the total adipocyte population, beige adipo-
cytes can exert marked effects on systemic energy
balance.
Our data suggest that the increase in glucose utilization
provoked by Tle3 deletion is likely due to increased ex-
pression of glucose transporters and genes involved in mi-
tochondrial oxidative phosphorylation. Gene ontology
analysis pointed to broad changes in expression in meta-
bolic pathways in the absence of TLE3, including compo-
nents of the electron transport chain, heat production,
fatty acid oxidation, and the TCA cycle. Loss of Tle3
also led to enhanced energy expenditure under conditions
where mice had more beige adipocytes. In the cold, mice
lacking Tle3 in adipocytes lost more weight, an outcome
that was largely attributed to increased energy expendi-
ture. This was also seen in vitro, where beige adipocytes
lacking Tle3 had increased basal respiration and uncoupl-
ing. When mice were challenged with a HFD, they were
protected against diet-induced weight gain at ambient
temperature, a condition that leads to mild activation of
thermogenesis. Improvements in glucose metabolism
were also associated with reduced expression of a subset
of adipose tissue fibrosis genes, which has been implicated
recently in improving systemic glucose metabolism
(Hasegawa et al. 2018). Althoughwe suspect that beige ad-
ipocytes contribute to protection against weight gain, it is
possible that loss of Tle3 in BAT is also contributing to
changes in body weight (Villanueva et al. 2013). These
findings parallel those that are observed with the loss of
ZFP423, where there is increased abundance of beige adi-
pocytes in subcutaneous WAT (Shao et al. 2016). Like
ZFP423, TLE3 expression in adipose tissue reprograms
BAT to WAT (Villanueva et al. 2013). Future studies ex-
ploring the relationship between TLE3 and ZFP423 may
provide new insights into the transcriptional control of
white adipocytes.
Although TLE3 has been studied broadly during devel-
opment, there has heretofore been little known about its
genome-wide distribution in adipocytes. By integrating
RNA-seq andChIP-seq analysis, we identified putative ge-
nomic targets of TLE3. Most of these were found in distal
genomic regions that were >25 kb from the TSS. Given
that TLE3 lacks a DNA-binding domain, we performed
motif analysis on genomic regions associated with TLE3
and found that C/EBP and EBF motifs were highly associ-
ated with TLE3 binding. Our analysis also supports an
overlap in genome-wide occupancy of TLE3 and PPARγ,
where 23% of TLE3-binding sites were associated with
PPARγ, while 41% of PPARγ-binding sites overlap with
TLE3. After analyzing TLE3-binding sites near genes reg-
ulated by TLE3 in beige adipocytes, we found that EBF2
and TLE3 colocalized near genes activated with the loss
of TLE3. This led us to investigate the cross-talk between
TLE3 and EBFs. We found that TLE3 interacted with
EBF2, repressed EBF2 target genes, and repressed EBF2
transcriptional activity in a reporter assay and an Ebf2
knockdown experiment. Furthermore, we found that
genes that are repressed by TLE3 were more likely to con-
tain an EBF motif compared with those that were en-
hanced by TLE3. There was a high degree of overlap
between TLE3- and EBF2-binding sites near genes that
were repressed by TLE3, and the TLE3-binding intensity
was consistently higher at sites near TLE3-repressed
genes. Previously, we found that TLE3 disrupts the inter-
action between PPARγ and PRDM16. One would suspect
that a similar mechanism may be involved, in which
TLE3 disrupts the interaction between EBF2 and
PRDM16. Together, our findings suggest a new mecha-
nism by which TLE3 attenuates the beige adipocyte
gene expression program by serving as a molecular brake
on EBF2.
In conclusion, we identified TLE3 as a negative regula-
tor of EBF2 and the beige adipocyte program, whose ac-
tions block energy expenditure, glucose utilization, and
mitochondrial energetics. Developing therapeutics that
target TLE3 may provide opportunities to prevent weight
gain associated with diet.
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Materials and methods
Animals
A conditional knockout allele for Tle3 was generated on a 129/
OlaHsd and C57BL/6J background, as has been described (Villa-
nueva et al. 2013).Tle3flox/floxmicewere bred for nine generations
to a C57BL/6J background. To obtain age-matched littermates,
Tle3flox/flox mice were bred to Tle3flox/flox Adipoq-Cre BAC trans-
genic mice bred for nine generations by the Jackson Laboratories
to a C57BL/6J background. Male mice age 3–4 mo that expressed
the Adipoq-Cre transgene were compared with male littermate
controls lacking the Cre transgene.
Mice were housed at 22°C–24°C under a 12-h light/dark cycle
with ad libitum access to food and water, except when food was
withdrawn for an experiment. Animals were maintained on a
Teklad global soy protein-free diet (2920x) except where noted
otherwise.
Cell culture
Preadipocytes isolated from the stromal vascular fraction of in-
guinal white fat depots were isolated as described previously (Ro-
dríguez-Cuenca et al. 2007); cells were immortalized by retroviral
expression of the SV40 large T antigen (Addgene, 13970) using a
hygromycin selection marker and expressing MSCV CreERT2
(Addgene, 22776) using a puromycin selection marker. Adenovi-
rus was amplified using Phoenix-ECO cells. Adenovirus vectors
were purified by CsCl gradient.
Preadipocytes were plated in a 12-well plate in DMEM, 10%
FBS, 20 nM insulin, and 1 nM T3 with a seeding density of 0.1 ×
106 cells per well. Upon confluence, cells were differentiated us-
ing DMEM medium containing 10% fetal bovine serum (FBS)
(RBMI, FBS-BBT-5XM), 20 nM insulin, 1 nM T3, 0.5 mM isobu-
tylmethylxanthine, 0.5 µM dexamethasone, 0.125 mM indo-
methacin, and 1 µM rosiglitazone. After 2 d, the medium was
changed to DMEM, 10% FBS, 20 nM insulin, 1 nM T3, and 1
µM rosiglitazone. On the fourth day, cells were given either
500 nM 4-hydroxytamoxifen to induce knockout of TLE3 or an
equivalent volume of ethanol or DMSO as a control.
Cell staining
After 10 d of differentiation, cells were washed three times in 1×
PBS, fixed with freshly prepared PBS+4% formaldehyde for 1 h,
and then incubated with DAPI (Thermo Fisher, D3571) and
1 µg/mL Bodipy (Thermo Fisher, D3922) for 20 min. Cells were
subsequently washed three times in 1× PBS and visualized by
GFP and DAPI channels. Following DAPI and Bodipy visualiza-
tion, cells were stained using stock solution Oil Red O (0.5 g in
100 mLof isopropanol; Sigma-Aldrich,O0625) diluted to a freshly
prepared working solution (6 mL of stock solution and 4 mL of
ddH2O) and incubated for 1 h.
Western blot analysis
Cells were homogenized using radioimmunoprecipitation assay
(RIPA) buffer (Boston Bioproducts, Inc.) plus proteinase inhibitor
cocktail (SigmaAldrich, 04693124001) and lysed using a 25-gauge
needle. Protein was extracted from flash-frozen tissues in RIPA
buffer with protease inhibitor cocktail using a glass dounce.
Cell or tissue homogenate was spun at 10,000g for 10 min at
4°C, and the concentration of the supernatant was measured us-
ing the Pierce BCA protein assay kit (Thermo Fisher, 23225). Pro-
tein samples (10–20 µg per lane) were denatured in Laemmli
loading buffer, heated for 20 min at 70°C, resolved by SDS-
PAGE gels (typically 10%), and transferred to nitrocellulose
membranes (GE Healthcare). Membranes were probed for TLE3
(Proteintech, 11372-1-AP; Abcam, ab213596), UCP1 (Abcam,
ab10983), PPARγ (Proteintech, 22061-1-AP), β-actin (Cell Signal-
ing, 4970 and 3700), HMGB1 (Abcam, ab18256), V5 (Thermo
Fisher, 46-0705), EBF2 (R&D Systems, AB213596), or Flag M2
(Millipore-Sigma, F3165).
For analysis of mitochondrial oxidative phosphorylation pro-
teins, protein samples were denatured in Laemmli loading buffer,
heated for 20 min at 50°C, resolved by SDS-PAGE gels (5%–20%
gradient; Bio-Rad), and transferred to a PVDFmembrane (Bio-Rad)
in CAPS buffer (10 mM CAPS, 10%methanol at pH 11.0). Mem-
branewas probed using the Total OXPHOS rodent antibody cock-
tail (Abcam, ab110413).
Gene expression
Total RNA was isolated using Trizol reagents (Thermo Fisher,
15596018) and reverse-transcribed using SS VILO Mastermix
(Thermo Fisher, 11755500). Gene expression of TLE3was quanti-
fied using TaqMan Universal Master Mix II (Applied Biosystems,
4440038) and Quant Studio 6 instrument (Applied Biosystems by
Invitrogen). All other transcripts were quantified by real-time
qPCR using KAPA SYBR Fast Rox Low (Kapa Biosystems,
KK4621). Primer sequences are shown in Supplemental Table S2.
In vitro glucose uptake
Tle3F/F iWAT preadipocytes were plated in a 12-well plate, al-
lowed to reach confluence, and then stimulated to differentiate.
After 2 d, the medium was changed to DMEM, 10% FBS, 20 nM
insulin, 1 nMT3, and 1 µM rosiglitazone. On the fourth day, cells
were given either 500 nM 4-hydroxytamoxifen to induce knock-
out of Tle3 or an equivalent volume of ethanol as a control. On
the 10th day, the cells were incubated in DMEM, 10% FBS,
20 nM insulin, and 1 nM T3 (no rosiglitazone) for 3 h at 37°C.
Cells were washed twice in warm 1× PBS solution and incubated
with 0.1 uCi of 2-[14C(U)]-deoxy-D-glucose (Perkin Elmer,
NEC720A050UC) per well with unlabeled 2-deoxy-D-glucose
up to 6.5 mM total glucose concentration. Negative control wells
were also given 20 µM cytochalasin B. After 5 min of incubation,
cells werewashed three times in 1× PBS solution at 4°C, and then
1 mL of PBSwith 1%SDSwas added to eachwell to lyse the cells.
After 10 min of incubation, the cell mixture was mixed by pi-
pette. A sample was taken for measuring protein concentration,
and another sample was taken to measure radioactivity by liquid
scintillation counter in Ultima Gold MV (Perkin Elmer,
6013159). Scintillation counts were normalized to total protein
concentration.
Dual-luciferase reporter assay
iWAT preadipocytes were plated and differentiated with the dif-
ferentiation cocktail described above. Four days after differentia-
tion, the cellswere trypsinized and plated in a 48-well platewith a
seeding density of 20,000 cells per well. After 24 h, the cells were
cotransfectedwith 50 ng of pGL3-firefly luciferase reporter vector
(Promega, E1960) driven by the Cldn1 enhancer element, 1 ng of
Renilla luciferase vector (Promega, E1960), and separate expres-
sion vectors containing 50 ng of GFP, 50 ng of Ebf2, and/or
100 ng of TLE3. Cldn1 enhancer element was cloned out using
the following primers: Fwd-GTGGCGATGACAAGGTGATA
and Rev-ATAGCTACTCAGTTCCACATTCC. Cells were trans-
fected using Lipofectamine 3000. The next day, cellswerewashed
and lysed. Twenty microliters of cell lysate was incubated with
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the luciferase assay substrate, and both firefly andRenilla lucifer-
ase activities weremeasured. Renilla luciferase activity was used
as an assay control.
Knockdown of Ebf2
siRNA to Ebf2 was purchased (IDT) in the TriFECTa RNAi kit
(mm.Ri.Ebf2.13.1, mm.Ri.Ebf2.13.2, and mm.Ri.Ebf2.13.3).
Scrambled siRNA (NC1) or a mixture of siEbf2 oligos was trans-
fected into mature beige adipocytes using Lipofectamine RNAi-
MAX (Invitrogen) for 4 h on day 12 of differentiation.
Prolonged cold exposure and thermoneutrality
For cold experiments, male mice age 3–4 mo were put for 4 d at
2°C–8°C. For thermoneutrality experiments, male mice age 3–
4 mo were put for 1 wk at 30°C.
Energy expenditure
Energy expenditure, food andwater intake, and ambulatory activ-
ity were determined by using comprehensive laboratory animal-
monitoring system (CLAMS; Columbus Instruments). Animals
were housed individually within the metabolic cages on a 12-h
light/dark cycle with ad libitum access to food (chow diet) and
water. System temperature was set at 4°C and remained at 4°C–
5°C throughout the run. Energy expenditure was calculated as a
function of oxygen consumption and carbon dioxide production
in the CLAMS cages. Energy expenditure = [3.815+1.232 ×
(VCO2/VO2)] ×VO2.
Histology
Adipose tissue was fixed in 4% buffered formaldehyde and em-
bedded in paraffin. Sections were stained with H&E using stan-
dard protocols.
GTT and ITT
A GTT was administered to fasting mice for 6 h with free access
to water during fasting, and fasting blood glucose levels were
measured using a glucometer by tail bleeds.Micewere then given
an intraperitoneal injection of glucose (1 mg/g). Blood glucose
levels were measured in intervals (0, 15, 30, 60, 120 min after in-
jection) to determine how quickly the glucose was cleared from
the blood.
An ITT was administered in a similar manner but using intra-
peritoneally injected insulin (Lilly, NDC 0002-8215-17HI-213) at
0.75 U/kg or 1.0 U/kg for mice on a HFD.
In vivo glucose uptake
MaleTLE3F/F Adipoq-Cremice and their littermate controls were
placed for 4 d at 2°C–8°C with free access to food and water. On
the fourth day,micewere fasted for 6 h and given a tail vein injec-
tion of 4 uCi of 2-[14C(U)]-dexoxy-D-glucose (Perkin Elmer,
NEC720A050UC) in 1× PBS. Blood samples were taken at 0, 5,
10, 20, and 30 min to monitor clearance of radioactive glucose
from the blood. After 30 min, animals were sacrificed, and tissues
were weighed and dissolved in 1 mL of NaOH for 1 h at 60°C.
Samples were neutralized. One part of homogenate was used to
determine the content of unphosphorylated glucose. This sample
was deproteinated by adding equivalent volumes of 0.3 M Ba
(OH)2 and 0.3 M ZnSO4 and centrifuged, and the
14C content of
the supernatant was measured by liquid scintillation counting.
Another part of the homogenate was used to determine the con-
tent of total glucose. Insoluble proteins in this sample were re-
moved by adding 6% HClO4 and centrifuging, and the
14C
content of the supernatant was measured by liquid scintillation
counting. The amount of phosphorylated 2-[14C(U)]-deoxy-D-glu-
cosewas then determined by subtracting the radioactivity counts
of the unphosphorylated sample from radioactivity counts of the
total sample and normalizing to tissue weight.
HFD
Where noted, male Tle3F/F Adipoq-Cre and littermate controls
were put on a 60% HFD (Research Diets, D12492) starting at
2 mo of age and maintained for 14 wk. Weight was measured
weekly.
Body composition/MRI measurements
Composition of lean tissue, fat mass, and fluid was analyzed us-
ing the Bruker Minispec LF50 body composition analyzer.
TLE3 ChIP-seq
Cells from the stromal vascular fraction of BAT (pooled interscap-
ular, cervical, and axillary depots) as well as the eWAT and iWAT
ofmaleNMRImicewere obtained and differentiatedwith rosigli-
tazone as described previously (Siersbaek et al. 2012). Mature ad-
ipocytes were analyzed at day 7, and only cultures with at least a
50% degree of differentiation were used.
For preparation of material for TLE3 ChIP-seq, eWAT-, iWAT-,
and BAT-derived adipocytes were treated with 2 mM disuccini-
midyl glutarate (Proteochem) for 15 min followed by cross-link-
ing with 1% formaldehyde for 30 min. Cross-linking was
stopped by addition of glycine. Nucleus isolation, chromatin
preparation, and ChIP were performed as described previously
(Siersbaek et al. 2012). The ChIP was performed using anti-
TLE3 (Proteintech, 11372-1-AP). ChIP-seq libraries were con-
structed according to the manufacturer’s instructions (Illumina)
as described in Nielsen and Mandrup (2014).
TLE3 ChIP-seq data analysis
ChIP-seq data sets were mapped to the mm9 genome with
STAR (Dobin et al. 2013) set to not map across splice junctions,
as described previously (Brier et al. 2017), and tag directory gen-
eration, peak calling/annotations, and motif analyses were per-
formed with HOMER (Heinz et al. 2010). TLE3-binding sites
were called using “-style factor” and “-F 10” settings with all
other parameters set at default in eWAT-, iWAT-, and BAT-de-
rived adipocytes, and overlapping peaks were merged into one
master peak file. Subsequently, TLE3 peaks in each condition
were identified as having >15 normalized tags per peak in a
230-bp window and 10-fold more tags relative to the input con-
trol. For known and de novo motif analyses, we used HOMER’s
findMotifsGenome.pl with default settings in the indicated
groups of TLE3-binding sites. The background comparison
used randomly selected regions that had similar GC content.
For comparison with PPARγ- and EBF2-binding profiles, data
sets were obtained from the Gene Expression Omnibus (GEO)
under accession numbers GSE41481 and GSE97116, respective-
ly. Mapping and peak calling were performed with a strategy
similar to that used for TLE3 ChIP-seq data. PPARγ profiles
were divided into binding sites (>25 tags per peak and 10-fold
more tags than input) with high TLE3 binding (i.e., 25 tags
per window and 10-fold more tags than input) and no TLE3
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binding (<15 tags per window). To determine genomic co-occur-
ence of EBF2 and TLE3 binding, we defined TLE3-binding sites
near the indicated gene groups and used HOMER’s mergePeaks
program to count the literal overlaps of binding sites. Further-
more, EBF2 tag counts were summarized in a 230-bp window
in TLE3-binding sites near the indicated gene groups.
The University of California at Santa Cruz (UCSC) Genome
Browser (Kent et al. 2002) was used for visualization of genome
tracks.
EBF2 ChIP-seq for genome tracks
EBF2 ChIP-seq data from immortalized BAT preadipocytes differ-
entiated for 2 d in cultures were obtained fromGSM1913014 (Lai
et al. 2017).
DNase-seq for genome tracks
The DNase-seq data from in vitro differentiated eWAT, iWAT,
and BAT primary adipocytes is available under GEO accession
number GSE122417.
Gene expression profile—input data
Intact poly(A) RNA was purified from total RNA samples (100–
500 ng) with oligo(dT) magnetic beads, and stranded mRNA se-
quencing libraries were prepared as described using the Illumina
TruSeq stranded mRNA library preparation kit (RS-122-2101 and
RS-122-2102). Purified libraries were qualified on an Agilent
Technologies 2200 TapeStation using a D1000 ScreenTape assay
(catalog nos. 5067-5582 and 5067-5583). The molarity of adapter-
modified molecules was defined by qPCR using the Kapa Biosys-
tems Kapa library quantification kit (KK4824). Individual librar-
ies were normalized to 10 nM, and equal volumes were pooled
in preparation for Illumina sequence analysis.
Sequencing libraries (25 pM) were chemically denatured and
applied to an IlluminaHiSeq v4 single-read flow cell using an Illu-
mina cBot. Hybridizedmolecules were clonally amplified and an-
nealed to sequencing primers with reagents from an Illumina
HiSeq SR cluster kit v4-cBot (GD-401-4001). Following transfer
of the flow cell to an Illumina HiSeq 2500 instrument (HCS ver-
sion 2.2.38 and RTA version 1.18.61), a 50-cycle single-read se-
quence run was performed using HiSeq SBS kit version 4
sequencing reagents (FC-401-4002).
Gene expression profile—analysis
Fastq sequences were aligned with Novoalign (version 2.8)
against themouse genome (UCSC releasemm9) with splice junc-
tions. Alignments to splice junctions were converted to genomic
coordinates with USeq SamTranscriptomeParser (version 8.8.8).
RNA-seq quality was evaluated by running Picard CollectRna-
SeqMetrics. Differential gene expression was identified using
the USeq application DefinedRegionDifferentialSeq (version
8.8.8), which counts alignment tags over collapsed Ensembl
gene annotation, executes the R DESeq2 application, filters the
gene results at log2 ratio of 1.0 and −10log10(adjusted P) of 20,
and reports the results.
The resulting gene lists were used for functional enrichment
analysis (gene ontology) using the Panther classification system
(Mi et al. 2017) and Reactome pathway (Fabregat et al. 2018)
databases.
Heat map
The heat map was created at Shinyheatmap (http://www
.shinyheatmap.com) using Euclidiean distance metrics and com-
plete linkage algorithms (Khomtchouk et al. 2017).
Data availability
RNA-seq data are available from GEO under accession number
GSE116894. ChIP-seq data are available from GEO under acces-
sion number GSE116767.
Statistical analysis
Data are presented as mean±SEM unless stated otherwise. Stu-
dent’s t-test was used to determined significance unless stated
otherwise.
Study approval
Animal experiments were conducted with the approval of the In-
stitutional Animal Care andUse Committee (IACUC) of theUni-
versity of Utah.
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